PepTalk’s Antibody Discovery & Engineering pipeline offers a unique meeting combination for protein scientists working to discover and develop unique and differentiated biotherapeutics quickly and efficiently. For 2022,
these conference tracks explore how cutting-edge discovery and engineering technologies have combined with lessons learned from the expansive efforts to develop Covid-19 vaccines and therapeutics to drive a new paradigm in biotherapeutics research.
At the early stage, emphasis is on the use of the addition of predictive methods to screening platforms, while the engineering program explores creative new ways of reaching cells of interest and resolving unmet medical needs.
Optimizing Biotherapeutic Discovery
Biotherapeutic Targeting Strategies
If you are working in the following areas join the PepTalk community:
- Antibody Discovery
- Antibody Engineering
- Antibody Technologies
- Biologics Development
- Biotherapeutics Development
- Cellular Engineering
- Protein Engineering
- Protein Sciences
- Regulatory Affairs